Consonance Capital Partners logo

Consonance Capital Partners

North America, New York, United States, New York

Description

Consonance Capital Partners is a healthcare investment firm that invests broadly across the healthcare landscape.

Investor Profile

Consonance Capital Partners has made 9 investments, with 0 in the past 12 months and 22% as lead.

Stage Focus

  • Post Ipo Equity (33%)
  • Private Equity (22%)
  • Pre Seed (11%)
  • Series Unknown (11%)
  • Series B (11%)
  • Series A (11%)

Country Focus

  • United States (67%)
  • Nigeria (11%)
  • United Kingdom (11%)
  • Canada (11%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Manufacturing
  • Finance
  • Financial Services
  • Fintech
  • Education
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Consonance Capital Partners frequently co-invest with?

Aidi Ventures
North America, California, United States, San Jose
Co-Investments: 1
Hustle Fund
North America, California, United States, San Carlos
Co-Investments: 1
Ventures Platform
North America, Prince Edward Island, Canada, Victoria
Co-Investments: 1
Y Combinator
North America, California, United States, Mountain View
Co-Investments: 1
DFS Lab
North America, Washington, United States, Seattle
Co-Investments: 1
CO
Europe, Vaduz, Liechtenstein, Vaduz
Co-Investments: 1
Mercy Corps Ventures
North America, Oregon, United States, Portland
Co-Investments: 1
Launch Africa
Africa, Plaines Wilhems, Mauritius, Ebène
Co-Investments: 1
Sherpa Africa Partners
Africa, Nairobi Area, Kenya, Nairobi
Co-Investments: 1
Future Africa
North America, California, United States, San Francisco
Co-Investments: 1

Which angels does Consonance Capital Partners often collaborate with?

AH
North America, California, United States, Irvin
Shared Deals: 1
CK
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Consonance Capital Partners?

Civic Eagle

Minneapolis, Minnesota, United States

Civic Eagle develops software that helps companies discover and analyze legislation and regulations with no manual work.

B2BSaaSSoftware
Series AMay 11, 2022
Amount Raised: $10,000,000
Surrozen

South San Francisco, California, United States

Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.

BiotechnologyEmergency MedicineHealth Care
Post Ipo EquityAug 12, 2021
Amount Raised: $120,000,000
PayHippo

Lekki, Lagos, Nigeria

PayHippo is an AI-Driven lending platform making it easier to finance small and medium sized businesses.

FinanceFinancial ServicesFinTech
Pre SeedJul 1, 2021
Amount Raised: $1,100,000
Silence Therapeutics

London, England, United Kingdom

Silence Therapeutics is a drug development company with a proprietary genetic medicine platform.

BiotechnologyHealth CareInformation TechnologyMedicalTherapeutics
Post Ipo EquityFeb 18, 2021
Amount Raised: $45,499,905
Mersana Therapeutics

Cambridge, Massachusetts, United States

Mersana Therapeutics develops a biodegradable polymer platform Fleximer® which creates new and better medicines.

BiotechnologyHealth CareMedicalTherapeutics
Post Ipo EquityApr 7, 2020
Amount Raised: $65,000,000
Bako Diagnostics

Alpharetta, Georgia, United States

Bako Diagnostics is a provider of diagnostic and therapeutic services in the healthcare industry.

Health CareMedicalTherapeutics
Private EquityJan 7, 2016
Telesta Therapeutics

Pointe-claire, Quebec, Canada

Telesta Therapeutics is a biopharmaceutical company focused on the licensing, acquisition, and development of transformational therapeutics.

BiotechnologyManufacturingPharmaceuticalTherapeutics
Series UnknownAug 20, 2015
Amount Raised: $28,600,000
Enclara Pharmacia

Philadelphia, Pennsylvania, United States

Enclara Pharmacia offers clinical services, operation processes, and educational programs to improve patient care.

BiotechnologyEducationHealth CareHospitalMedicalPharmaceutical
Private EquityMar 1, 2014
Corindus

Waltham, Massachusetts, United States

Corindus develops and commercializes remote robotic systems for interventional procedures.

ManufacturingMedical DeviceRobotics
Series BApr 14, 2008
Amount Raised: $12,000,000